
EIF4G (Ab 1232) Antilichaam
Kwaliteit
ISO Gecertificeerd
Levering
24-48 uur
Technische Specificaties
EIF4F is a multi-subunit complex, the composition of which varies with external and internal environmental conditions. It is composed of at least EIF4A, EIF4E and EIF4G1/EIF4G3. Interacts with eIF3, mutually exclusive with EIF4A1 or EIFA2, EIF4E and through its N-terminus with PAPBC1. Interacts through its C-terminus with the serine/threonine kinases MKNK1, and with MKNK2. Appears to act as a scaffold protein, holding these enzymes in place to phosphorylate EIF4E. Non-phosphorylated EIF4EBP1 competes with EIF4G1/EIF4G3 to interact with EIF4E; insulin stimulated MAP-kinase (MAPK1 and MAPK3) phosphorylation of EIF4EBP1 causes dissociation of the complex allowing EIF4G1/EIF4G3 to bind and consequent initiation of translation. EIF4G1/EIF4G3 interacts with PABPC1 to bring about circularization of the mRNA. Rapamycin can attenuate insulin stimulation mediated by FKBPs. Interacts with EIF4E3. Interacts with MIF4GD. Interacts with rotavirus A NSP3; in this interaction, NSP3 takes the place of PABPC1 thereby inducing shutoff of host protein synthesis
1981
Q04637
NP_004944.2
• Rabbit
Human, Mouse, Rat
EIF4G (Ab-1232) antibody was raised against a peptide sequence around aa.1230~1234 (P-V-S-P-L) derived from Human eIF4G.
• Polyclonal
Unconjugated
Primary Antibodies
Other
Antibodies were purified by affinity-chromatography using epitope-specific peptide.
1 mg/mL
Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
None
Blue Ice
Store antibody at -20˚ C for up to one year.
220 kDa
This antibody detects endogenous level of total eIF4G protein.
Western Blot: 1:500~1:1000, Immunohistochemistry: 1:50~1:100, Immunofluorescence: 1:100~1:200
EIF4G1
Eukaryotic translation initiation factor 4 gamma, 1
Homo sapiens
De Gregorio, E. et al. (1998) RNA 4, 828-836. Ohlmann, T. et al. (1996) EMBO J. 15, 1371-1382. Borman, A. M. and Kean, K. M. (1997) Virology 237, 129-136. Gradi, A. et al. (1998) Mol Cell Biol 18, 334-42.
P220, EIF4F, EIF4G, EIF4GI, PARK18, EIF-4G1, GAPD, CDABP0047, OK/SW-cl.12
WB, IHC, IF
38201619
Liquid
Beschrijving
EIF4G (Ab 1232) Antilichaam Beschikbaar in 0.1 mg. Bestel eenvoudig online met snelle levering.
Specificaties
Recent bekeken producten

Rat IgG Lyophilized
B2013903
25 mg

Fluorescent Nanodiamond in DI water, < 1ppm NV
NDNV20nmMd10ml
10 mL

Fluorescent Nanodiamond in DI water, ~3ppm NV
NDNV70nmHi10ml
10 mL

Ligation Buffer
LB001
1.4 mL

BioCoupler® x 12
BC12
12 Each

Recombinant Common timothy PHLPIV/Phl p 4 Protein, N-His
YZZ03001
100 μg

NP (4-hydroxy-3-nitrophenylacetate)
NP-BSA-03Low – 10 mg
10 mg

NP (4-hydroxy-3-nitrophenylacetate)
NP-BSA-03High – 10 mg
10 mg
Recent gezochte producten

NIT2 Human qPCR Primer Pair (NM_020202)
HP213556
200 Reactions

NIT2 (NM_020202) Human Tagged ORF Clone
RC210660
10 µg

Human NIT2 (NM_020202) AAV Particle
RC210660A1V
250 µL

NIT2 (NM_020202) Human Tagged ORF Clone
RG210660
10 µg

NIT2 (NM_020202) Human Untagged Clone
SC108295
10 µg

NIT2 (NM_020202) Human 3' UTR Clone
SC204925
10 µg

LHX9 (NM_020204) Human 3' UTR Clone
SC210775
10 µg

Anti-h ST2 10202 SPTN-5
MBS5680565-01
1 mg
